The US Food and Drug Administration (FDA) has concluded that inaccurate results from the point-of-care device used to measure international normalized ratio (INR) values in warfarin-treated patients ...
The European Medicines Agency (EMA) has concluded that a defect with the international normalised ratio (INR) device used in the ROCKET study does not change its conclusions on the overall safety or ...
LONDON, UK — The key ROCKET AF trial used a faulty point-of-care device to measure INR in its comparator arm of patients taking warfarin, which may have made warfarin results look worse than they ...
My doctor has approved use of the Phillips Self Testing PT/INR machine. Medicare will pay 80 percent of the test strip cost. Does TRICARE cover PT/INR self testing? Thank you. Anna G. Via the Internet ...
The faulty device used in the ROCKET AF trial to monitor anticoagulation in patients randomly assigned to receive warfarin compared with the group receiving rivaroxaban (Xarelto, Bayer/Johnson & ...
Warfarin anticoagulation reduces thromboembolic complications in patients with atrial fibrillation or mechanical heart valves, but effective management is complex, and the international normalized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback